Search Results for "Solid Tumors With Neuroendocrine Features"
Original Source: Solid papillary carcinoma of the breast with neuroendocrine features in a pregnant woman: a case report.
Solid papillary carcinoma, a special form of breast carcinoma with neuroendocrine differentiation, usually presents in women aged 60 years or more. (Koern, 2010). According to our best knowledge, we present the second case of such a tumor in pregnant women.
Matching Channels
A tumor or tumour is the name for a neoplasm or a solid lesion formed by an abnormal growth of cells (termed neoplastic) which looks like a swelling. Tumor is not synonymous with cancer. A tumor can...
Matching News
Neuroendocrine Tumors Can't Hide From DOTATATE PET
Imaging with gallium-68 DOTATATE PET/CT can help doctors choose the most appropriate treatment for patients with neuroendocrine tumors. Medscape Medical News
Chemo combo promising for pancreatic neuroendocrine tumors
(HealthDay) -- The combination of temozolomide and bevacizumab seems to benefit patients with advanced pancreatic neuroendocrine tumors (NETs), according to a study published online July 9 in the Jour...
Whole Exome Sequencing of Small Intestine Neuroendocrine Tumors May Lead to Development of ...
Whole exome sequencing of small intestine neuroendocrine tumors, the most common malignancy of the small bowel, revealed genomic alterations...
Liver Transplant for Unresectable Neuroendocrine Tumor Metastases
Liver transplantation is effective when liver metastases from neuroendocrine tumors are unresectable, according to a European Liver Transplant Registry study. Reuters Health Information
Peptide-receptor radionuclide therapy (PRRT) has been a subject of growing research on neuroendocrine tumors, which take up residence in a variety of organs replete with nerve cells that respond to ho...
Roche, Chiasma to develop Octreolin for acromegaly, neuroendocrine tumors
Basel, Switzerland-based Roche and Chiasma, a privately held biopharmaceutical company, have entered into an agreement to develop and commercialize Chiasma's proprietary product Octreolin, initially f...
Moffitt Cancer Center researcher & colleagues test new drug for patients with neuroendocrine tumors
(H. Lee Moffitt Cancer Center & Research Institute) A researcher at Moffitt Cancer Center and his international team of colleagues have reported study results on a novel multireceptor-targeted somatos...
(H. Lee Moffitt Cancer Center & Research Institute) A researcher at Moffitt Cancer Center and his international team of colleagues have reported study results on a novel multireceptor-targeted somatos...
Matching PubMed Articles
PAX (paired box) genes encode a family of transcription factors important for organogenesis. Recently, PAX8 has been recognized as a potential immunohistochemical marker of pancreatic neuroendocrine t...
Neuroendocrine tumors are considered rare tumors: recently an increased incidence and an improvement in survival were described. We explore distribution, incidence and survival of neuroendocrine tumor...
BACKGROUND: Pancreatic tumors are rare in children, resulting in limited information regarding their frequency and imaging appearances. OBJECTIVE: To review all pancreatic tumors seen in children over...
Somatostatin receptor endoradiotherapy of neuroendocrine tumors: experience in Hungarian patients.
Beside conventional therapies for the treatment of neuroendocrine tumors, a new therapeutical approach, peptide receptor radionuclide therapy has been developed recently. There are two important featu...
Ectopic hormone secretion by neuroendocrine tumors.
Ectopic hormone production is a rare complication in neuroendocrine tumors. Tumors producing corticotropin-releasing hormone (CRH) and adrenocorticotropic hormone (ACTH) are most commonly observed, le...
